← Leaderboards
Minmin Yen
Phagepro, Inc.
$3,099,664
Attributed
$5,199,327
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,199,327 · 5
By mechanism
R44$3,904,818 · 2
R41$738,041 · 1
R21$383,168 · 1
R34$173,300 · 1
Top collaborators
- Andrew Camilli10 shared
Others in their field
Other Emerging Leaders on “Cholera”
- Ansel Hsiao · University Of California Riverside$8,095,435
- Stefan Pukatzki · University Of Colorado Denver$4,193,912
- Tobias Doerr · Cornell University$3,917,047
- Natalie Exner Dean · University Of Florida$3,573,200
- Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ$3,378,368
- Andrew Wang · Yale University$2,853,345
Research focus
CholeraBacteriophagesProphylactic TreatmentBacteriaPreventOryctolagus CuniculusVibrio CholeraeAntibioticsCommunitiesInfantInvestmentsCholera VaccineCountryDiarrheal DiseaseResourcesPreventiveHouseholdContaminated WaterAnimalsContractsDoseOralPreventionResistance
Grant awards (11)
Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail$1,000,000
R44 · FY2025 · AI · contact PI
Preparation of a Phase I/II safety and efficacy trial for a cholera phage cocktail intervention$173,300
R34 · FY2024 · AI · contact PI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$930,046
R44 · FY2023 · AI · contact PI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$975,187
R44 · FY2022 · AI · contact PI
Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis$204,527
R21 · FY2022 · AI · contact PI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$999,585
R44 · FY2021 · AI · contact PI
Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis$178,641
R21 · FY2021 · AI · contact PI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$300,000
R41 · FY2020 · AI · contact PI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$83,041
R41 · FY2020 · AI · contact PI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$55,000
R41 · FY2020 · AI · contact PI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$300,000
R41 · FY2019 · AI · contact PI